{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T10:38:58Z","timestamp":1648982338101},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T00:00:00Z","timestamp":1280966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s11936-010-0089-2","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T01:36:42Z","timestamp":1280885802000},"page":"431-442","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Resynchronization Therapy in Asymptomatic or Mildly Symptomatic Heart Failure Patients"],"prefix":"10.1007","volume":"12","author":[{"given":"Helmut U.","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,5]]},"reference":[{"key":"89_CR1","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","volume":"106","author":"DM Lloyd-Jones","year":"2002","unstructured":"Lloyd-Jones DM, et al.: Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002, 106:3068\u20133072.","journal-title":"Circulation"},{"key":"89_CR2","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIRCULATIONAHA.106.179918","volume":"115","author":"W Rosamond","year":"2007","unstructured":"Rosamond W, et al.: Heart disease and stroke statistics\u20142007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69\u2013e171.","journal-title":"Circulation"},{"issue":"15","key":"89_CR3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"SA Hunt","year":"2009","unstructured":"Hunt SA, et al.: American College of Cardiology Foundation\/American Heart Association. 2009 Focused update incorporated into the ACC\/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2009, 53(15):e1\u2013e90.","journal-title":"J Am Coll Cardiol"},{"key":"89_CR4","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.106.666818","volume":"115","author":"KA Ammar","year":"2007","unstructured":"Ammar KA, et al.: Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology\/American Heart Association heart failure staging criteria in the community. Circulation 2007, 115:1563\u20131570.","journal-title":"Circulation"},{"key":"89_CR5","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","volume":"119","author":"M Jessup","year":"2009","unstructured":"Jessup M, et al.: 2009 focused up-date: ACCF\/AHA Guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119:1977\u20132016.","journal-title":"Circulation"},{"key":"89_CR6","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2004.08.016","volume":"44","author":"JJ Bax","year":"2004","unstructured":"Bax JJ, et al.: Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004, 44:1834\u20131840.","journal-title":"J Am Coll Cardiol"},{"key":"89_CR7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCULATIONAHA.108.773838","volume":"118","author":"JP Picini","year":"2008","unstructured":"Picini JP, et al.: Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation 2008, 118:926\u2013933.","journal-title":"Circulation"},{"key":"89_CR8","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1001\/jama.297.22.2502","volume":"297","author":"FA McAlister","year":"2007","unstructured":"McAlister FA, et al.: Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 2007, 297:2502\u20132514.","journal-title":"JAMA"},{"key":"89_CR9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"AE Epstein","year":"2008","unstructured":"Epstein AE, et al.: ACC\/AHA\/HRS2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the ACC\/AHA Task force on Practice Guidelines developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 51:e1\u2013e62.","journal-title":"J Am Coll Cardiol"},{"key":"89_CR10","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","volume":"350","author":"MR Bristow","year":"2004","unstructured":"Bristow MR, et al.: Cardiac-Resynchronization Therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140\u20132150. This very important paper demonstrates for the first time in a large patient cohort that overall mortality can be significantly reduced with CRT despite optimal medical treatment in patients with severe heart failure (NYHA III\/IV). Most benefit is achieved by adding an ICD to CRT (CRT-D).","journal-title":"N Engl J Med"},{"key":"89_CR11","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","volume":"352","author":"JGF Cleland","year":"2005","unstructured":"Cleland JGF, et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539\u20131549.","journal-title":"N Engl J Med"},{"key":"89_CR12","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2005.09.016","volume":"46","author":"P Carson","year":"2005","unstructured":"Carson P, et al.: Mode of death in advanced heart failure. The comparison of medical, pacing, and defibrillation therapies in heart failure (COMPANION) trial. J Am Coll Cardiol 2005, 46:2329\u20132334.","journal-title":"J Am Coll Cardiol"},{"key":"89_CR13","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1161\/CIRCULATIONAHA.106.642892","volume":"114","author":"LA Saxon","year":"2006","unstructured":"Saxon LA, et al.: Predictors of sudden death and appropriate shock in the comparison of medical therapy, pacing, and defibrillation therapies in heart failure (COMPANION) trial. Circulation 2006, 114:2766\u20132772.","journal-title":"Circulation"},{"key":"89_CR14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.108.793273","volume":"119","author":"IS Anand","year":"2009","unstructured":"Anand IS, et al.: Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure. Circulation 2009, 119:969\u2013977.","journal-title":"Circulation"},{"key":"89_CR15","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehl099","volume":"27","author":"JGF Cleland","year":"2006","unstructured":"Cleland JGF, et al.: Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the Cardiac Resynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006, 27:1928\u20131932.","journal-title":"Eur Heart J"},{"key":"89_CR16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacc.2008.04.036","volume":"52","author":"JGF Cleland","year":"2008","unstructured":"Cleland JGF, et al.: Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response. J Am Coll Cardiol 2008, 52:438\u2013445. This important paper confirms the overall benefit of CRT, even without ICD backup, in NYHA III\/IV patients followed up over a longer period of 37 months. Although longer follow-up also shows that sudden death can be reduced by CRT alone, the outcome of this trial would have been even more positive if CRT were combined with ICD therapy.","journal-title":"J Am Coll Cardiol"},{"key":"89_CR17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/CIRCULATIONAHA.106.629261","volume":"115","author":"JA Lindenfeld","year":"2007","unstructured":"Lindenfeld JA, et al.: Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association Class IV heart failure. Circulation 2007, 115:204\u2013212.","journal-title":"Circulation"},{"key":"89_CR18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/eurjhf\/hfq003","volume":"12","author":"B Vidal","year":"2010","unstructured":"Vidal B, et al.: Decreased likelihood of response to cardiac resynchronization in patients with severe heart failure. Eur J Heart Fail 2010, 12:283\u2013287.","journal-title":"Eur J Heart Fail"},{"key":"89_CR19","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(03)01042-8","volume":"42","author":"SL Higgins","year":"2003","unstructured":"Higgins SL, et al.: Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrythmias. J Am Coll Cardiol 2003, 42:1454\u20131459.","journal-title":"J Am Coll Cardiol"},{"key":"89_CR20","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1161\/01.CIR.0000146336.92331.D1","volume":"110","author":"WT Abraham","year":"2004","unstructured":"Abraham WT, et al.: Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004, 110:2864\u20132868.","journal-title":"Circulation"},{"key":"89_CR21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","volume":"52","author":"C Linde","year":"2008","unstructured":"Linde C, et al.: Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008, 52:1834\u20131843.","journal-title":"J Am Coll Cardiol"},{"key":"89_CR22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","volume":"361","author":"AJ Moss","year":"2009","unstructured":"Moss AJ, et al.: Cardiac resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009, 361:1329\u20131338. This landmark trial (MADIT-CRT), with the largest patient cohort ever analyzed, showed that CRT combined with ICD therapy can prevent heart failure progression, reduce heart failure hospitalization, and markedly reduce ventricular remodeling within a 2.5-year follow-up in patients with no or only mild heart failure symptoms (NYHA I\/II).","journal-title":"N Engl J Med"},{"key":"89_CR23","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.108.818724","volume":"120","author":"M St. John.Sutton","year":"2009","unstructured":"St. John.Sutton M, et al.: Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association Class I\/II heart failure. Circulation 2009, 120:1858\u20131865.","journal-title":"Circulation"},{"key":"89_CR24","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.jacc.2009.08.011","volume":"54","author":"C Daubert","year":"2009","unstructured":"Daubert C, et al.: Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction. J Am Coll Cardiol 2009, 54:1837\u20131846. This paper deals with a substudy of the first NYHA I\/II heart failure trial (REVERSE), demonstrating that heart failure progression, as well as ventricular remodeling, can be achieved with continuous CRT during a longer follow-up of 2 years, although the primary end point of the main study was not met after a 12-month follow-up.","journal-title":"J Am Coll Cardiol"},{"key":"89_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCHEARTFAILURE.109.884395","volume":"3","author":"AF Hernandez","year":"2010","unstructured":"Hernandez AF, et al.: Clinical effectiveness of implantable cardioverter-defibrillators among Medicare beneficiaries with heart failure. Circ Heart Fail 2010, 3:7\u201313.","journal-title":"Circ Heart Fail"},{"key":"89_CR26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.hrthm.2008.12.017","volume":"6","author":"CJ Borleffs","year":"2009","unstructured":"Borleffs CJ, et al.: Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy. Heart Rhythm 2009, 6:305\u2013310.","journal-title":"Heart Rhythm"},{"key":"89_CR27","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.jacc.2005.01.071","volume":"46","author":"A Kashani","year":"2005","unstructured":"Kashani A, et al.: Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005, 46:2183\u20132192.","journal-title":"J Am Coll Cardiol"},{"key":"89_CR28","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/CIRCULATIONAHA.109.910778","volume":"121","author":"BK Fornwalt","year":"2010","unstructured":"Fornwalt BK, et al.: Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation 2010, 121:1985\u20131991.","journal-title":"Circulation"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-010-0089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-010-0089-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-010-0089-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:37Z","timestamp":1559436997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-010-0089-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1007\/s11936-010-0089-2","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,5]]}}}